Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,519 | -45,711 | -25,987 | -14,490 | -3,760 |
| Depreciation Amortization | 17 | 19 | 6 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,384 | 38 | 1,211 | 1,620 | 571 |
| Other Working Capital | 4,818 | 1,445 | -652 | -1,269 | 290 |
| Other Operating Activity | -5,112 | 3,394 | 1,146 | -379 | -531 |
| Operating Cash Flow | $-10,412 | $-40,815 | $-24,276 | $-14,518 | $-3,430 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -99 | -200 | -117 | -69 | N/A |
| Investing Cash Flow | $-99 | $-200 | $-117 | $-69 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4 | 82,133 | 7 | 7 | N/A |
| Other Financing Activity | 0 | 92,852 | 91,487 | 92,760 | 84,854 |
| Financing Cash Flow | $4 | $174,985 | $91,494 | $92,767 | $84,854 |
| Beginning Cash Position | 139,198 | 5,228 | 5,228 | 5,228 | 5,228 |
| End Cash Position | 128,691 | 139,198 | 72,329 | 83,408 | 86,652 |
| Net Cash Flow | $-10,507 | $133,970 | $67,101 | $78,180 | $81,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,412 | -40,815 | -24,276 | -14,518 | -3,430 |
| Capital Expenditure | -99 | -200 | -117 | -69 | N/A |
| Free Cash Flow | -10,511 | -41,015 | -24,393 | -14,587 | -3,430 |